Alecensa
Active substance: alectinib
alectinib hydrochloride
Centralised EU authorisationActive
Marketing holder: Roche Registration GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 3 |
|
| US 2 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-33f4-7f65-984b-0a5bff83c41b,01a120c3-ce27-7ece-a8a7-bae401ca3d12,01a120c5-24f1-79b5-991f-3b0f4c251f0f;count=3 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-3060-7c9c-8262-e38ff629e5de,01a1209a-bc05-74e9-8025-0626d44e2760;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004164
- Registration status
- Active
- ATC code
- L01ED03
Sources
- product · EMA · EMEA/H/C/004164 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004164 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004164 · Verified 2026-10-09